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Summary
Introduction: Individuals who are exposed to a traumatic event are at increased risk of
developing psychiatric disorders such as posttraumatic stress disorder (PTSD). Studies have
shown that increased amygdala activity is frequently found in patients with PTSD. In addition,
pre-trauma glucocorticoid receptor (GR) number in peripheral blood mononuclear cells (PBMCs)
has been found to be a significant predictor for the development of PTSD symptoms. Research in
rodents has shown that the response of basolateral amygdala neurons to corticosterone is
mediated by GR. However, to the best of our knowledge, no previous study has investigated
GR number in PBMCs and amygdala function in humans.
Methods: To investigate whether peripheral GR number is related to amygdala functioning, we
assessed GR number in PBMCs of healthy soldiers before their deployment to Afghanistan.
Amygdala functioning was assessed with fMRI before and after deployment.
Results: We found that pre-deployment GR number was significantly negatively correlated to
pre-deployment amygdala activity. More importantly, pre-deployment GR number predicted the
increase in amygdala activity by deployment.
Discussion: Our results demonstrate that peripheral GR number is associated with amygdala
functioning and predicts the increase in amygdala activity following military deployment in
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healthy individuals who did not develop PTSD. It is uncertain how this relationship is mediated
mechanistically, but future studies should examine the relation of GR and amygdala activity to
determine whether this is part of a common pathway leading to increased vulnerability to stress-
related disorders.
# 2012 Elsevier Ltd. 
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Individuals who are exposed to a traumatic event (such as
natural disasters, terrorism, assault, or military combat) are
at riskof developing psychiatric disorders such as posttraumatic
stress disorder (PTSD). In the last decades knowledge of the
lasting consequences of traumatic stress on the neurobiology of
individuals has increased rapidly. Functional neuroimaging
studies have revealed that patients with PTSD show exagger-
ated amygdala responses and deficient prefrontal cortex func-
tion, in particular in the anterior cingulate cortex and
ventromedial prefrontal cortex (Rauch et al., 2000; Shin
et al., 2001, 2005). These neural alterations in PTSD probably
result from both stress exposure and stress vulnerability
(Admon et al., 2009; Shin et al., 2009). In a recent study, we
investigated soldiers before and after their first deployment to
a combat zone (van Wingen et al., 2011). Our results demon-
strated that combat stress increases amygdala and insula
reactivity to biologically salient stimuli, and that impaired
prefrontal cortex—amygdala coupling was associated with per-
ceived threat. Follow-up showed that amygdala responsivity
normalizes within 1.5 years after deployment in resilient indi-
viduals that do not develop PTSD, but that perceived threat-
dependent changes in amygdala coupling with the dorsal ante-
rior cingulate cortex persist (van Wingen et al., 2012).
In addition to these neurobiological changes, numerous
studies have also shown that PTSD is associated with increased
sensitivity of the hypothalamic—pituitary—adrenal axis (HPA-
axis) to negative feedback by glucocorticoids (GCs) (Yehuda
et al., 1995, 2002; Golier et al., 2006; de Kloet et al., 2006,
2007a,b). Recently, we reported that the pre-trauma gluco-
corticoid receptor number in peripheral blood mononuclear
cells (PBMCs) was higher within soldiers who developed a high
level of PTSD symptoms after deployment to Afghanistan
compared to matched controls who did not develop PTSD
symptoms (van Zuiden et al., 2011, 2012). Although the per-
ipheral GR pathway is often considered to be an accessible
model for GR signaling in the brain, it remains unclear if and
how peripheral GR functioning is related to CNS activity.
Preclinical research has shown that the response of basolateral
amygdala neurons to corticosterone is mediated by GR (Karst
et al., 2010; Arnett et al., 2011; Groeneweg et al., 2011).
Whether GR number in PBMCs is a reliable reflection of GR
number in the brain has not been studied extensively. Pre-
clinical studies have shown that the affinity and specificity for
GCs of neuronal and lymphoid GRs are similar (Lowy, 1989). In
addition, GRs in both brain and peripheral immune tissues are
downregulated after chronic corticosterone administration
(Spencer et al., 1991). However, to our knowledge, no previous
study has investigated the relation between peripheral GR and
amygdala function in humans. We hypothesized that GR num-
ber in PBMCs would be related to amygdala functioning in
healthy individuals. In addition, we hypothesized that GRnumber in PBMCs would be associated with the amygdala
response in reaction to severe stress.
To investigate whether peripheral GR is related to amyg-
dala functioning, we assessed GR number in PBMCs in soldiers
before deployment to Afghanistan. Amygdala functioning
was assessed with functional magnetic resonance imaging
(fMRI) in the same group of soldiers before and 1.5 months
after deployment.
2. Methods
2.1. Participants
Participants included in this study consisted of twenty-four
healthy soldiers who were deployed for 4 months to Afghani-
stan as part of the NATO International Security Assistance Force
(ISAF) peacekeeping operation. They were recruited from a
larger prospective study on the development of stress-related
disorders following military deployment in the Dutch armed
forces. None of the participants had been deployed previously.
Duties during deployment included combat patrols, clearing or
searching homes and buildings, participation in demining
operations, and transportation across enemy territory. They
were exposed to typical war-zone stressors such as enemy fire,
armed combat, and seeing seriously injured fellow soldiers and
civilians (including women and children). The study was in
accordance with the declaration of Helsinki and institutional
guidelines of the local ethics committee (CMO Arnhem-Nijme-
gen, the Netherlands and the Institutional Review Board of the
University Medical Center Utrecht, the Netherlands), and all
participants provided written informed consent after written
and oral description of the study.
2.2. Procedure
Participants were investigated several weeks prior to deploy-
ment to Afghanistan. A venous blood sample was drawn for
assessment of the number of GR binding sites in PBMCs.
Participants filled in a number of paper-and-pencil question-
naires. Since GR is associated with glucose regulation, and
polymorphisms of the GR gene are associated with metabolic
parameters and body composition (van Rossum and Lam-
berts, 2004), we also measured the body-mass index (BMI)
prior to deployment. BMI was calculated from the self-
reported weight and length of the participants. In addition,
all participants received an fMRI scan before and 1.5 months
after deployment.
2.3. Questionnaires
A previously validated Dutch questionnaire, the Self-rating
Inventory for PTSD, was used to assess self-reported PTSD
GR number and amygdala activity 1839symptoms (Hovens et al., 1994). We included all healthy
soldiers who were deployed for 4 months to Afghanistan.
As it is quite plausible that GR concentrations and amygdala
activity would be altered in those individuals who develop
PTSD both prior to deployment and after, one participant who
scored above the clinical threshold for PTSD symptoms after
deployment was therefore excluded from the analyses. Expo-
sure to potential traumatic experiences before the age of 18
was assessed using the Dutch version of the short form self-
report version of the Early Trauma Inventory (Bremner et al.,
2007; Rademaker et al., 2008). This questionnaire consists of
27 dichotomous items. The total score represents the number
of experienced events. To quantify stress exposure, we
measured combat exposure during deployment using the
combat experience scale of the Deployment Risk and Resi-
lience Inventory (Vogt et al., 2008).
2.4. Cortisol
Plasma cortisol levels were measured by electrochemilumi-
nescence immunoassay on the Modular E170 (Roche Diagnos-
tics, Mannheim, Germany). Lower limit of detection was
3 nmol/l; interassay variation was <3%; and reference values
(0700—1000 h) were 170—540 nmol/l.
2.5. GR binding sites in PBMCs
For determination of the capacity of PBMCs to bind glucocor-
ticoids a validated whole cell single point binding assay was
used as described previously. This method provides a reliable
estimate of Bmax as determined using a classical binding assay
with 3—200 nM 3H-dexamethasone (r2 = 0.92) (van Zuiden
et al., 2009, 2011). Briefly, PBMCs were isolated from whole
blood using Ficoll-Paque (Pharmacia, Uppsala, Sweden) and
107 cells were frozen in DMSO. After thawing and 60 min
equilibration in culture medium, cells were washed twice,
resuspended in assay buffer (RPMI-1640 with 5% FCS) and
incubated in duplicate with 100 nM 3H-dexamethasone (Amer-
sham, Buckinghamshire, UK) in the presence or absence of
excess unlabeled dexamethasone (Sigma—Aldrich, Steinheim,
Germany) for 1 h at 37 8C. Cell bound radioactivity was quan-
tified by liquid scintillation analysis.
2.6. MRI data acquisition
MR data were acquired with a 1.5 T Siemens (Erlangen, Ger-
many) Avanto MR scanner, equipped with a standard head coil.
T2*-weighted BOLD images were acquired using EPI with an
echo time of 35 ms to reduce signal dropout in the medial
temporal lobes. Each image volume consisted of 32 axial slices
(3.5 mm, 0.35 mm slice-gap, TR = 2.340 s, 64  64 matrix,
FOV = 212 mm, FA = 908). In addition, a high-resolution T1-
weighted structural MR image with optimized gray/white
matter contrast was acquired (3D MP-RAGE, 1  1  1 mm3
voxels, TR = 2.730 s, TE = 2.95 ms, TI = 1000 ms, FOV =
256 mm, FA = 78).
2.7. Behavioral task
The experimental paradigm that was performed during func-
tional MRI scanning consisted of a blocked design, including acondition with angry and fearful face stimuli (http://
www.macbrain.org) and a visuo-motor control condition with
scrambled ellipse stimuli, a task specifically designed to elicit
amygdala activity (Hariri et al., 2002; van Wingen et al.,
2011). Two blocks of angry and fearful faces were interleaved
with three control blocks, and each 30 s block consisted of six
5 s trials. Each trial consisted of three simultaneously pre-
sented stimuli, with the cue stimulus presented above the
target and distractor. In the faces condition, an angry or
fearful face was presented on top as cue, and participants
had to indicate by an appropriate button press which of the
bottom two faces (one angry and one fearful) matched the
cue in emotional expression. In the control condition, a
horizontally or vertically oriented ellipse was presented as
cue above two ellipses (one vertical and one horizontal), and
participants had to select the identically oriented ellipse.
2.8. Data analysis
Image analysis was performed with SPM5 (http://www.fil.io-
n.ucl.ac.uk/spm). The first five EPI-volumes were discarded
and the remaining images were realigned to the first volume.
Images were then coregistered to the anatomical scan,
corrected for differences in slice acquisition time, spatially
normalized to the MNI T1 template, resampled into
2  2  2 mm3 voxels, and spatially smoothed (8 mm FWHM).
Statistical analysis was performed within the framework of
the general linear model (Friston et al., 1994). To assess the
influence of combat stress on neural responsivity, the two
experimental conditions were modeled as box-car regressors
convolved with the canonical hemodynamic response func-
tion of SPM5. In addition, the realignment parameters were
included to model potential movement artifacts, as well as a
constant. Furthermore, a high-pass filter (cut-off 1/128 Hz)
was included, and temporal autocorrelation was modeled
with an AR(1) process. Contrast images subtracting the visuo-
motor control condition from the emotion condition were
obtained, and analyzed in subsequent random effects mod-
els.
Voxel-wise statistical tests were family-wise error (FWE)
rate corrected ( p < 0.05) for multiple comparisons across
the entire brain, or for the search volume for regions of
interest using a small volume correction (SVC) (Worsley
et al., 1996). The search volume for the amygdala was
anatomically defined using the WFU Pickatlas toolbox imple-
mented in SPM5 (Maldjian et al., 2003). For the correlation
and regression analyses with GR number, the imaging data
were extracted from the amygdala mask (see Fig. 1). Pearson
correlation analyses and linear hierarchical regression ana-
lysis were performed using PASW Statistics 18.0, p < 0.05
(two-tailed) was considered significant. Data were assessed
for the presence of significant outliers. One of the partici-
pants had a GR number which deviated >2 SD from the mean
and was therefore excluded from the analyses.
3. Results
3.1. Demographics
The participants that were included for the analysis were
22 male soldiers who had been deployed to Afghanistan.
Figure 1 Amygdala mask used for extraction of imaging data.
Table 1 Participant characteristics.
Participants (n = 22)
Mean SD
Age 24.0 6.6
BMI prior to deployment (kg/m2) 24.2 1.4
Plasma cortisol prior to
deployment (nmol/l)
410.23 207.12
ISCED level 2.5 0.5
Smoking (yes/no) 11/11
Early life trauma (number of
experiences)
3.0 2.1
Combat experiences 5.4 2.6
PTSD symptoms pre-deployment 27.6 4.7
PTSD symptoms post-deployment 27.9 6.2
ISCED — International Standard Classification of Education; early
life trauma was measured with a checklist (Bremner et al., 2007).
PTSD symptoms measured with the 22 item self-report PTSD scale
(Hovens et al., 1994), range of possible scores 22—110. The
change in PTSD symptoms was not significant (paired samples
t-test, p = 0.860).
1840 E. Geuze et al.Participant characteristics are reported in Table 1. We
measured combat exposure during deployment to quantify
stress exposure. The average score for combat exposure
(mean  SD; 5.4  2.6) was comparable to that of a pre-
viously reported reference population of Gulf War veterans
(4.0  3.2) (King et al., 2006). None of the participants were
physically injured during deployment.
3.2. Behavioral performance
Prior to deployment, task accuracy was similar in both con-
ditions (median  IQR; faces condition: 100.0  10, control
condition: 94.4  6; p = 0.279) but reaction times were
slower in the faces condition (mean  SD; faces condition:
2059  474 ms, control condition: 1151  260 ms; T = 9.76,
p < 0.001). After deployment, task accuracy was also
similar in both conditions (median  IQR; faces condition:
100.0  8, control condition: 100.0  6; p = 0.529), and
again reaction times were slower in the faces condition
(mean  SD; faces condition: 1994  291 ms, control condi-
tion: 1140  405 ms; T = 9.82, p < 0.001). There were noTable 2 Brain regions with larger responses during the face matchi
of fMRI task).
MNI coordinates 
x 
R/L inferior occipitotemporal cortex 42 
R inferior frontal gyrus 50 
R amygdala 20 
L amygdala 18 
L inferior frontal gyrus 46 
L parahippocampal gyrus 8 
L middle temporal gyrus 58 
R parahippocampal gyrus 16 
Supplementary motor area 2 
L inferior parietal lobule 32 
R calcarine gyrus 10 
L inferior frontal gyrus 36 
Precuneus 4 
Data are local maxima for significant clusters ( p < 0.05, FWE, clustersignificant changes in accuracy ( p = 0.199) or reaction time
( p = 0.659) over time. In addition, the interaction of time -
 condition was not significantly different for both accuracy
( p = 0.528) and reaction time ( p = 0.600).
3.3. Neural responsivity
To verify that the task indeed activated the amygdala, we
compared the faces condition with the control condition
across measurements. As expected, the task increased
activity in the amygdala, as well as in the insula, dorsal
anterior  cingulate cortex (dACC), occipitotemporal cortex,
hippocampus, orbitofrontal cortex, inferior and middle
frontal gyri, thalamus, precuneus, angular gyrus, and cer-
ebellum (all pcor < 0.05; see Table 2). The increase in amyg-
dala activity of individuals after deployment, was trendng condition than during the control condition (i.e., main effect
Cluster size t
y z
48 20 8455 15.4
24 28 1227 11.6
6 14 222 11.5
6 14 306 9.9
18 32 706 9.1
30 4 92 7.7
46 8 112 7.3
30 2 98 7.2
14 54 49 6.9
58 52 26 6.7
74 6 52 6.7
30 0 36 6.5
54 48 66 6.3
  20 voxels). Cluster size in number of voxels.
Figure 2 GR number in PBMCs prior to deployment is signifi-
cantly correlated with amygdala activity prior to deployment (A)
but not to amygdala activity after deployment (B). GR number is
also significantly associated with the increase in amygdala ac-
tivity after deployment (C).
GR number and amygdala activity 1841significant, after small volume correction (peak Montreal
Neurological Institute coordinate (x, y, z); (26, 2, 26),
Z = 2.9, pcor = 0.076).
3.4. GR number in PBMCs and amygdala activity
Pre-deployment GR number in PBMCs was significantly
negatively correlated to pre-deployment amygdala activity
(Pearson’s R = 0.465, p = 0.029; see Fig. 2A), but not to
post deployment amygdala activity (Pearson’s R = 0.213,
p = 0.340). The difference between the correlations of
pre-deployment GR with pre- and post-deployment amygdala
activation is significantly different (Steiger’s Z = 2.41,
p = 0.016). The partial correlation of GR and baseline amyg-
dala activation, controlling for BMI was Pearson’s R = 0.468,
p = 0.033. More importantly, we also examined if GR number
in PBMCs was associated with the amygdala response in
reaction to severe stress. Pre-deployment GR number in
PBMCs was significantly correlated to the increase in amyg-
dala activity after deployment (Pearson’s R = 0.525,
p = 0.012; see Fig. 2B). In order to control for age, body-
mass index (BMI), and combat experiences, we entered these
into a linear hierarchical regression analysis with GR number.
To illustrate the unique effects of the variables, these were
entered in separate blocks (see Table 3). GR number was
entered into the first block, age and BMI in the second block
and combat experiences in the third block. Linear regression
analysis significantly predicted the increase in amygdala
activity after deployment (linear regression, F = 3.931,
p = 0.019, R2 = 0.480, adjusted R2 0.358; see Table 3). Both
GR number (b = 0.571, p = 0.005) and BMI (b = 0.438,
p = 0.034) were significant predictors of the increase in
amygdala activity after deployment. As expected, PTSD
symptom severity change (within these healthy individuals
with little variation in PTSD scores) was not correlated with
amygdala activation change (Pearson’s R = 0.068, p = 0.794).
To assess the anatomical specificity of the associations
between GR number and amygdala activity, additional
voxel-wise correlations were performed. Pre-deployment
GR number was negatively correlated to amygdala activity
(MNI coordinates (x, y, z); left: (18, 6, 20), Z = 3.3,
pcor = 0.026; right: (22, 2, 22), Z = 3.0, pcor = 0.57).
Furthermore, pre-deployment GR number was positively
correlated to the increase in amygdala activity after deploy-
ment (left: (20, 2, 16), Z = 2.9, pcor = 0.077; right: (20,
2, 20), Z = 3.6, pcor = 0.009). No significant correlations
with other brain regions were observed after correcting for
multiple comparisons, suggesting that GR number primarily
predicts amygdala functioning.
4. Discussion
In this study, we investigated whether peripheral GR number,
which has been shown to be a predictor for the development
of PTSD symptoms after combat exposure (van Zuiden et al.,
2011, 2012), was related to amygdala functioning in healthy
individuals exposed to severe stress. We assessed GR number
in PBMCs in soldiers before deployment to Afghanistan.
Amygdala functioning was assessed with functional magnetic
resonance imaging (fMRI) in the same group of soldiers before
and after deployment. The increase in amygdala activity
Table 3 Linear regression of age, BMI, and predeployment GR number in PBMCs on the increase in amygdala activity after military
deployment (N = 22).
Block 1
F1,21 = 7.613
*
R2 = 0.276
Block 2
F3,21 = 5.071
**
R2 = 0.458
Block 3
F4,21 = 3.931
***
R2 = 0.480
Variable b t p b t p b t p
GR number 0.525 2.759 0.012 0.575 3.268 0.004 0.571 3.225 0.005
Age 0.032 0.171 0.866 0.108 0.516 0.613
BMI 0.441 2.340 0.031 0.438 2.309 0.034
Combat experiences 0.168 0.857 0.403
BMI, body mass index; GR, glucocorticoid receptor; PBMCs, peripheral blood mononuclear cells; all variables were forced into entry in three
separate blocks to illustrate the unique effects of the variables. GR number was entered into the first block, age and BMI in the second block,
and combat experiences in the third block.
* p = 0.012.
** p = 0.010.
*** p = 0.019.
1842 E. Geuze et al.after deployment was trend significant ( p = 0.076). This was
due to a lower number of participants in this study compared
to our previous study (van Wingen et al., 2011). Pre-deploy-
ment GR number was significantly correlated with pre-
deployment amygdala activity. More importantly, pre-
deployment GR number significantly predicted a substantial
proportion of variance in the increase in amygdala activity
following deployment. Thus it appears that high GR number
in PBMCs not only is a vulnerability factor for PTSD (van
Zuiden et al., 2011, 2012), but may also lead to increased
amygdala activity after experiencing severe stress. Interest-
ingly, a recent study in mice with high trait anxiety revealed
increased levels of hippocampal GR protein and mRNA
expression under non-stressed conditions, compared to mice
with low trait anxiety (Jakovcevski et al., 2011). In addition,
systemic injection of the glucocorticoid receptor antagonist
mifepristone (RU486) decreased the stress-induced activa-
tion of the HPA axis and the long-term anxiogenic effects of
stress observed in mice with high trait anxiety. This suggests
that a central GR pathway dysregulation may indeed be
associated with increased vulnerability for the development
of stress-related disorders.
It is well known that the amygdala plays an important role
in threat detection and is part of a larger salience network
(Davis and Whalen, 2001; Phelps and LeDoux, 2005; LeDoux,
2007). In a number of stress and anxiety related disorders,
such as PTSD and panic disorder, amygdala hyperactivity is
frequently found (Rauch et al., 2000; Shin et al., 2005; Etkin
and Wager, 2007). It is thus of particular interest that GR
receptor number (in PBMCs prior to deployment), which has
previously been shown to be a predictor of PTSD symptoms
(van Zuiden et al., 2011, 2012), also predicts the increase in
amygdala activation after deployment. Earlier work by
Kukolja et al. (2008) has shown that elevation of norepi-
nephrine and cortisol to moderate stress levels induces an
amygdala response bias to fear equivalent to amygdala
hyperactivity observed in patients with PTSD. Administration
of hydrocortisone sodium succinate (HCORT) led to increased
activation of the amygdala in veterans with and without PTSD
(Yehuda et al., 2009). However, in healthy individuals, the
administration of hydrocortisone actually reduces amygdala
responses (Henckens et al., 2010). It may be proposed thatcortisol increases amygdala activity only in the presence of
severe stress exposure, possibly through interaction with the
noradrenergic system (Valentino et al., 1983, 1993). Para-
doxically, although pre-deployment GR number was nega-
tively correlated with pre-deployment amygdala activity,
pre-deployment GR number actually predicted the increase
in amygdala activity after deployment. The significance of
this relationship is still unknown, although it could be specu-
lated that GR regulation of amygdala activity may be altered
due to exposure to severe stress. Assessment of post-deploy-
ment GR number could have shed more light on this issue.
Unfortunately we have no data available on post-deployment
GR number in these individuals.
Although it is unclear how pre-deployment GR number in
PBMCs is involved in amygdala functioning, it may be
hypothesized that GR number in PBMCs is a reflection of
central GR function. Glucocorticoid receptors are found
throughout the brain, particularly in limbic areas, such as
the amygdala (Meaney et al., 1985; Groeneweg et al., 2011).
Studies in rodents have shown that GR within the CNS plays an
important role in fear conditioning (Kohda et al., 2007;
Kolber et al., 2008) and extinction (Cai et al., 2006; Yang
et al., 2006). Glucocorticoids thus appear to modulate the
formation of emotional memories (see Rodrigues et al., 2009
for a review). Inactivation of GR within the amygdala leads to
persistent disruption of traumatic memories (possibly indi-
cating a novel direction for prevention of PTSD) (Tronel and
Alberini, 2007).
Mechanisms of central and peripheral GR regulation are still
poorly understood. In this study we made use of a peripheral
measure of GR number, which may not be a genuine reflection
of GR in CNS. However, research has shown that neuronal and
lymphoid cytosolic GRs are similar in glucocorticoid affinity
and specificity (Lowy, 1989). In addition, cytosolic GRs in both
brain and peripheral immune tissue are down-regulated after
administration of corticosterone following adrenalectomy
(Lowy, 1991; Spencer et al., 1991). It is thus noteworthy that
the current study demonstrates an association between per-
ipheral GR and central brain function. The availability of a
suitable radiotracer for GR would enable future studies to
examine central GR function using SPECT or PET (Steiniger
et al., 2008; Wuest et al., 2009).
GR number and amygdala activity 1843The current study illustrates the power of combining
diverse neurobiological techniques, to gain a broader under-
standing of mechanisms involved in exposure to severe stress
and development of stress-related disorders. However, there
are several limitations, which should be addressed. Caution
should be used in interpreting functionality from correla-
tional analyses, such as used in this study. The results of this
study point to a potentially interesting mechanism in which
glucocorticoid functioning could influence amygdala func-
tioning possibly through altered fear conditioning and thus
increase vulnerability for psychiatric disorders after expo-
sure to severe stress. Future research should also examine
the functional implications of increased GR number by taking
into account functional assessment of the HPA axis (e.g. a
dexamethasone suppression test). Unfortunately, this study
examined these effects in a limited number of participants,
thus these results should be replicated in a larger study.
Although, none of the participants were physically injured
during deployment, we did not assess actual blast exposure,
thus we cannot exclude the possibility that this could have
affected the results. The current study’s strength, a homo-
genous sample, is also its weakness, as it limits the general-
izability of the results. We only examined (relatively young)
males, who were exposed to a similar prolonged severely
stressful period. Future studies should examine the relation
of GR and amygdala activity in females, individuals exposed
to other stressful and traumatic events, and for differing
lengths of time. In addition, studies should examine how GR
and amygdala activity are related to the development of
PTSD by assessing GR and amygdala activity in a larger
prospective study of individuals exposed to trauma as well
as in patients with PTSD.
In conclusion, our results demonstrate that GR number in
PBMCs is related to amygdala activation in humans, and that
GR number in PBMCs prior to exposure to severe stress
predicts the increase in amygdala activity after exposure.
Although it remains unclear how this relationship is
mediated, this study has shown that it is a research topic
that deserves further exploration.
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